中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
6期
88-90
,共3页
曲美他嗪%通心络胶囊%老年%冠心病%疗效
麯美他嗪%通心絡膠囊%老年%冠心病%療效
곡미타진%통심락효낭%노년%관심병%료효
Trimetazidine%Tongxinluo%Elderly%Coronary artery disease%Efifcacy
目的:探讨曲美他嗪联合通心络胶囊治疗老年冠心病患者的临床疗效及应用价值。方法选择本院治疗的老年冠心病患者122例,采用数字表法分为两组,每组61例,对照组患者给予西医常规治疗,观察组患者在对照组治疗基础上联合使用曲美他嗪和通心络胶囊治疗,观察两组临床疗效。结果观察组患者治疗总有效率高于对照组患者,组间资料比较差异具有显著性(P<0.05)。观察组患者血脂改善幅度优于对照组患者,差异具有显著性(P<0.05)。两组患者随访6个月,观察组患者心绞痛发作次数、发作持续时间和ST段变化均优于对照组患者,差异具有显著性(P<0.05)。结论曲美他嗪联合通心络胶囊治疗老年冠心病疗效可靠,能够显著降低患者血脂水平,减少心绞痛发作次数和持续时间,值得在临床上大力推广使用。
目的:探討麯美他嗪聯閤通心絡膠囊治療老年冠心病患者的臨床療效及應用價值。方法選擇本院治療的老年冠心病患者122例,採用數字錶法分為兩組,每組61例,對照組患者給予西醫常規治療,觀察組患者在對照組治療基礎上聯閤使用麯美他嗪和通心絡膠囊治療,觀察兩組臨床療效。結果觀察組患者治療總有效率高于對照組患者,組間資料比較差異具有顯著性(P<0.05)。觀察組患者血脂改善幅度優于對照組患者,差異具有顯著性(P<0.05)。兩組患者隨訪6箇月,觀察組患者心絞痛髮作次數、髮作持續時間和ST段變化均優于對照組患者,差異具有顯著性(P<0.05)。結論麯美他嗪聯閤通心絡膠囊治療老年冠心病療效可靠,能夠顯著降低患者血脂水平,減少心絞痛髮作次數和持續時間,值得在臨床上大力推廣使用。
목적:탐토곡미타진연합통심락효낭치료노년관심병환자적림상료효급응용개치。방법선택본원치료적노년관심병환자122례,채용수자표법분위량조,매조61례,대조조환자급여서의상규치료,관찰조환자재대조조치료기출상연합사용곡미타진화통심락효낭치료,관찰량조림상료효。결과관찰조환자치료총유효솔고우대조조환자,조간자료비교차이구유현저성(P<0.05)。관찰조환자혈지개선폭도우우대조조환자,차이구유현저성(P<0.05)。량조환자수방6개월,관찰조환자심교통발작차수、발작지속시간화ST단변화균우우대조조환자,차이구유현저성(P<0.05)。결론곡미타진연합통심락효낭치료노년관심병료효가고,능구현저강저환자혈지수평,감소심교통발작차수화지속시간,치득재림상상대력추엄사용。
Objective To investigate the trimetazidine joint Tongxinluo treatment efifcacy and value of elderly patients with coronary artery disease. Method The hospital treated 122 cases of elderly patients with coronary artery disease, divided into two groups, each of 61 cases, the control group received conventional treatment, joint used of the observation group Trimetazidine and pass in the control group on the basis of Tongxinluo treatment, observed the clinical efficacy of the two groups. Result The treatment of patients in the observation group had higher overall efifciency, the difference was statistically signiifcant (P<0.05). Magnitude improvement in the observation group than the control group lipids, the difference was statistically signiifcant (P<0.05). Two groups of patients were followed up for 6 months, patients in the observation group angina attack frequency, duration and onset of ST segment changes than the control group, data were compared between the two groups, the difference was statistically signiifcant (P < 0.05). Conclusion Trimetazidine joint Tongxinluo treatment efifcacy in patients with coronary heart disease in elderly reliable, can signiifcantly lower blood lipid levels in patients and reduce the number and duration of angina pectoris, to promote worthy of clinical use.